The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

III.c

Hemoptysis

Publications

González A, Sagardía J, Redondo A, Villaverde M, Monteverde A

[Alveolar hemorrhage as a complication of thrombolytic therapy].

Medicina 2011;71;547-9 — 2011 — 547-9

Chang YC, Patz EF, Goodman PC, Granger CB

Significance of hemoptysis following thrombolytic therapy for acute myocardial infarction.

Chest 1996 Mar;109;727-9 — 1996 Mar — 727-9